The discrepancy may at least in part be resolved by the hypothesis that the timing of BRCA1 methylation will influence tumour phenotype; the earlier in tumorigenesis methylation occurs, the greater the similarity to tumours arising from germline BRCA1 mutations. The gene discussed is BRCA1; the disease is neoplasm.